Canine Influenza Treatment Market, Global Outlook and Forecast 2022-2028

July 2024 | 64 pages | ID: C40A8CA45043EN
Market Monitor Global

Abstracts

Canine influenza is also known as dog flu, and it is a contagious respiratory disease that spreads in an airborne and aerosolized manner in dogs, caused by Type A influenza viruses.

This report contains market size and forecasts of Canine Influenza Treatment in Global, including the following market information:

Global Canine Influenza Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Canine Influenza Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Canine Influenza Treatment include Merck Animal Health, Pfizer, Sanofi, Zoetis, Novartis, Bristol-Myers Squibb, Eli Lilly and Company, Boehringer Ingelheim International and Roche and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Canine Influenza Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Canine Influenza Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Canine Influenza Treatment Market Segment Percentages, by Type, 2021 (%)

• Antibiotics
• Nonsteroidal anti-inflammatory Drugs (NSAIDs)
• Antiviral Drugs
• Others

Global Canine Influenza Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Canine Influenza Treatment Market Segment Percentages, by Application, 2021 (%)

• Veterinary Clinics
• Veterinary Pharmacies
• Online Pharmacies
• Others

Global Canine Influenza Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Canine Influenza Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Canine Influenza Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Canine Influenza Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck Animal Health
• Pfizer
• Sanofi
• Zoetis
• Novartis
• Bristol-Myers Squibb
• Eli Lilly and Company
• Boehringer Ingelheim International
• Roche
• GlaxoSmithKline

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Canine Influenza Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Canine Influenza Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANINE INFLUENZA TREATMENT OVERALL MARKET SIZE

2.1 Global Canine Influenza Treatment Market Size: 2021 VS 2028
2.2 Global Canine Influenza Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Canine Influenza Treatment Players in Global Market
3.2 Top Global Canine Influenza Treatment Companies Ranked by Revenue
3.3 Global Canine Influenza Treatment Revenue by Companies
3.4 Top 3 and Top 5 Canine Influenza Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Canine Influenza Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Canine Influenza Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Canine Influenza Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Canine Influenza Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Canine Influenza Treatment Market Size Markets, 2021 & 2028
  4.1.2 Antibiotics
  4.1.3 Nonsteroidal anti-inflammatory Drugs (NSAIDs)
  4.1.4 Antiviral Drugs
  4.1.5 Others
4.2 By Type - Global Canine Influenza Treatment Revenue & Forecasts
  4.2.1 By Type - Global Canine Influenza Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Canine Influenza Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Canine Influenza Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Canine Influenza Treatment Market Size, 2021 & 2028
  5.1.2 Veterinary Clinics
  5.1.3 Veterinary Pharmacies
  5.1.4 Online Pharmacies
  5.1.5 Others
5.2 By Application - Global Canine Influenza Treatment Revenue & Forecasts
  5.2.1 By Application - Global Canine Influenza Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Canine Influenza Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Canine Influenza Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Canine Influenza Treatment Market Size, 2021 & 2028
6.2 By Region - Global Canine Influenza Treatment Revenue & Forecasts
  6.2.1 By Region - Global Canine Influenza Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Canine Influenza Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Canine Influenza Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Canine Influenza Treatment Revenue, 2017-2028
  6.3.2 US Canine Influenza Treatment Market Size, 2017-2028
  6.3.3 Canada Canine Influenza Treatment Market Size, 2017-2028
  6.3.4 Mexico Canine Influenza Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Canine Influenza Treatment Revenue, 2017-2028
  6.4.2 Germany Canine Influenza Treatment Market Size, 2017-2028
  6.4.3 France Canine Influenza Treatment Market Size, 2017-2028
  6.4.4 U.K. Canine Influenza Treatment Market Size, 2017-2028
  6.4.5 Italy Canine Influenza Treatment Market Size, 2017-2028
  6.4.6 Russia Canine Influenza Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Canine Influenza Treatment Market Size, 2017-2028
  6.4.8 Benelux Canine Influenza Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Canine Influenza Treatment Revenue, 2017-2028
  6.5.2 China Canine Influenza Treatment Market Size, 2017-2028
  6.5.3 Japan Canine Influenza Treatment Market Size, 2017-2028
  6.5.4 South Korea Canine Influenza Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Canine Influenza Treatment Market Size, 2017-2028
  6.5.6 India Canine Influenza Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Canine Influenza Treatment Revenue, 2017-2028
  6.6.2 Brazil Canine Influenza Treatment Market Size, 2017-2028
  6.6.3 Argentina Canine Influenza Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Canine Influenza Treatment Revenue, 2017-2028
  6.7.2 Turkey Canine Influenza Treatment Market Size, 2017-2028
  6.7.3 Israel Canine Influenza Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Canine Influenza Treatment Market Size, 2017-2028
  6.7.5 UAE Canine Influenza Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck Animal Health
  7.1.1 Merck Animal Health Corporate Summary
  7.1.2 Merck Animal Health Business Overview
  7.1.3 Merck Animal Health Canine Influenza Treatment Major Product Offerings
  7.1.4 Merck Animal Health Canine Influenza Treatment Revenue in Global Market (2017-2022)
  7.1.5 Merck Animal Health Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Canine Influenza Treatment Major Product Offerings
  7.2.4 Pfizer Canine Influenza Treatment Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Sanofi
  7.3.1 Sanofi Corporate Summary
  7.3.2 Sanofi Business Overview
  7.3.3 Sanofi Canine Influenza Treatment Major Product Offerings
  7.3.4 Sanofi Canine Influenza Treatment Revenue in Global Market (2017-2022)
  7.3.5 Sanofi Key News
7.4 Zoetis
  7.4.1 Zoetis Corporate Summary
  7.4.2 Zoetis Business Overview
  7.4.3 Zoetis Canine Influenza Treatment Major Product Offerings
  7.4.4 Zoetis Canine Influenza Treatment Revenue in Global Market (2017-2022)
  7.4.5 Zoetis Key News
7.5 Novartis
  7.5.1 Novartis Corporate Summary
  7.5.2 Novartis Business Overview
  7.5.3 Novartis Canine Influenza Treatment Major Product Offerings
  7.5.4 Novartis Canine Influenza Treatment Revenue in Global Market (2017-2022)
  7.5.5 Novartis Key News
7.6 Bristol-Myers Squibb
  7.6.1 Bristol-Myers Squibb Corporate Summary
  7.6.2 Bristol-Myers Squibb Business Overview
  7.6.3 Bristol-Myers Squibb Canine Influenza Treatment Major Product Offerings
  7.6.4 Bristol-Myers Squibb Canine Influenza Treatment Revenue in Global Market (2017-2022)
  7.6.5 Bristol-Myers Squibb Key News
7.7 Eli Lilly and Company
  7.7.1 Eli Lilly and Company Corporate Summary
  7.7.2 Eli Lilly and Company Business Overview
  7.7.3 Eli Lilly and Company Canine Influenza Treatment Major Product Offerings
  7.7.4 Eli Lilly and Company Canine Influenza Treatment Revenue in Global Market (2017-2022)
  7.7.5 Eli Lilly and Company Key News
7.8 Boehringer Ingelheim International
  7.8.1 Boehringer Ingelheim International Corporate Summary
  7.8.2 Boehringer Ingelheim International Business Overview
  7.8.3 Boehringer Ingelheim International Canine Influenza Treatment Major Product Offerings
  7.8.4 Boehringer Ingelheim International Canine Influenza Treatment Revenue in Global Market (2017-2022)
  7.8.5 Boehringer Ingelheim International Key News
7.9 Roche
  7.9.1 Roche Corporate Summary
  7.9.2 Roche Business Overview
  7.9.3 Roche Canine Influenza Treatment Major Product Offerings
  7.9.4 Roche Canine Influenza Treatment Revenue in Global Market (2017-2022)
  7.9.5 Roche Key News
7.10 GlaxoSmithKline
  7.10.1 GlaxoSmithKline Corporate Summary
  7.10.2 GlaxoSmithKline Business Overview
  7.10.3 GlaxoSmithKline Canine Influenza Treatment Major Product Offerings
  7.10.4 GlaxoSmithKline Canine Influenza Treatment Revenue in Global Market (2017-2022)
  7.10.5 GlaxoSmithKline Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Canine Influenza Treatment Market Opportunities & Trends in Global Market
Table 2. Canine Influenza Treatment Market Drivers in Global Market
Table 3. Canine Influenza Treatment Market Restraints in Global Market
Table 4. Key Players of Canine Influenza Treatment in Global Market
Table 5. Top Canine Influenza Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Canine Influenza Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Canine Influenza Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Canine Influenza Treatment Product Type
Table 9. List of Global Tier 1 Canine Influenza Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Canine Influenza Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Canine Influenza Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Canine Influenza Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Canine Influenza Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Canine Influenza Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Canine Influenza Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Canine Influenza Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Canine Influenza Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Canine Influenza Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Canine Influenza Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Canine Influenza Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Canine Influenza Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Canine Influenza Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Canine Influenza Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Canine Influenza Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Canine Influenza Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Canine Influenza Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Canine Influenza Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Canine Influenza Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Canine Influenza Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Merck Animal Health Corporate Summary
Table 31. Merck Animal Health Canine Influenza Treatment Product Offerings
Table 32. Merck Animal Health Canine Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Canine Influenza Treatment Product Offerings
Table 35. Pfizer Canine Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Canine Influenza Treatment Product Offerings
Table 38. Sanofi Canine Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Zoetis Corporate Summary
Table 40. Zoetis Canine Influenza Treatment Product Offerings
Table 41. Zoetis Canine Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Canine Influenza Treatment Product Offerings
Table 44. Novartis Canine Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bristol-Myers Squibb Corporate Summary
Table 46. Bristol-Myers Squibb Canine Influenza Treatment Product Offerings
Table 47. Bristol-Myers Squibb Canine Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly and Company Corporate Summary
Table 49. Eli Lilly and Company Canine Influenza Treatment Product Offerings
Table 50. Eli Lilly and Company Canine Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Boehringer Ingelheim International Corporate Summary
Table 52. Boehringer Ingelheim International Canine Influenza Treatment Product Offerings
Table 53. Boehringer Ingelheim International Canine Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Roche Corporate Summary
Table 55. Roche Canine Influenza Treatment Product Offerings
Table 56. Roche Canine Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 57. GlaxoSmithKline Corporate Summary
Table 58. GlaxoSmithKline Canine Influenza Treatment Product Offerings
Table 59. GlaxoSmithKline Canine Influenza Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Canine Influenza Treatment Segment by Type in 2021
Figure 2. Canine Influenza Treatment Segment by Application in 2021
Figure 3. Global Canine Influenza Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Canine Influenza Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Canine Influenza Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Canine Influenza Treatment Revenue in 2021
Figure 8. By Type - Global Canine Influenza Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Canine Influenza Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Canine Influenza Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Canine Influenza Treatment Revenue Market Share, 2017-2028
Figure 12. US Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Canine Influenza Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Canine Influenza Treatment Revenue Market Share, 2017-2028
Figure 24. China Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Canine Influenza Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Canine Influenza Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Canine Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Animal Health Canine Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Canine Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Canine Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Zoetis Canine Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Canine Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bristol-Myers Squibb Canine Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly and Company Canine Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Boehringer Ingelheim International Canine Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Roche Canine Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GlaxoSmithKline Canine Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)